Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-28 @ 1:30 AM
Study NCT ID:
NCT00903292
Status:
UNKNOWN
Last Update Posted:
2009-05-18
First Post:
2009-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
Sponsor:
National Cheng-Kung University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HR98004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Wu- Chou Su
Old Organization:
National Cheng-Kung University Hospital